RIPK1 and cancer: For instance, Cucolo et al. observed the expression level of RIPK1 is strongly associated with interferon-mediated resistance, and genetic deletion of RIPK1 in cancer cells leads to ICB failure by compromising chemokine secretion to decrease ARG1+ suppressive myeloid cells [14].